Amidst the buzz around an imminent COVID-19 vaccine to be available in near future, Hyderabad-based Medihauxe Pharma has announced that it is fully geared up to handle, store and distribute Corona Vaccine in both Telugu states as and when the vaccine is made available. 

A vaccine’s journey can be risky with underdeveloped infrastructure. If there’s a break in the cold chain as a vaccine has to be taken to many places, it will lose its potency. And the entire purpose is defeated.

“We have experience and expertise in handling temperature sensitive specialty medicine and Cold Chain Pharma Products, their storage and handling declares, Girish Bhat and P Manohar, MD and Director, Medihauxe Pharma. Our facility is the state-of-the-art one and the warehouse infrastructure is one of the best in the country. We equipped with the latest technology, coupled with time-tested systems, agile management to ensure world class service,” they added.

The first-ever, temperature-sensitive medicine cooling facility, 2-8 degrees, at distribution level has all the requisite infrastructure such as Cold Chain, Walk-in-Cold Rooms, Data Loggers, informed Bhat.

Medihauxe Pharma currently deals with medicine categories such as cancer; liver, lung, kidney and cardiac transplants. Its facilities are audited by international pharma majors. The currently the turnover of the company is Rs 180 crore and has 120 employees.